SCHEMBL6996069

SCHEMBL6996069

CCOC(=O)c1ccc(CC[C@H](CNC(=O)OC(C)(C)C)OS(C)(=O)=O)s1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.39
SYK P43405 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
ALDH1A1 P00352 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HPGD P15428 1/20 0.32
RECQL P46063 1/20 0.32
PTPRB P23467 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ABCB1 P08183 1/20 0.32
AR P10275 1/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
USP10 Q14694 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6996040 1.00 SERPINE1 (0.39) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL6996037 1.00 SERPINE1 (0.39) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL6998667 0.85 SERPINE1 (0.39) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL6998671 0.85 SERPINE1 (0.39) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL6989772 0.84 HDAC3 (0.41) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL6989769 0.84 HDAC3 (0.41) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL6992685 0.84 HDAC3 (0.41) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL8689908 0.83 HDAC3 (0.40) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL8685226 0.83 HDAC3 (0.40) SERPINE1SYKHDAC3HDAC4HDAC1
SCHEMBL8685235 0.83 HDAC3 (0.40) SERPINE1SYKHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0846111-B1 SYNTHESES OF OPTICALLY PURE COMPOUNDS USEFUL AS GARFT INHIBITORS AND THEIR INTERMEDIATES AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-5981748-A Synthesis of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1999-11-09 US disclosed
US-5831100-A Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates AGOURON PHARMACEUTICALS, INC. (US) 1998-11-03 US disclosed